Fractured politics, disruptive technologies and a distrust in institutions are making it harder to focus on the traditional tasks of growing sales and profits.
Category: Pharmaceutical Research and Manufacturers of America
-
What C.E.O.s Are Worried About
The New York Times – Business: -
Six Reasons Drug Prices Are So High in the U.S.
Research shows prices in the United States are nearly double those in other well-off countries.
-
Drugmakers Throw ‘Kitchen Sink’ to Halt Medicare Price Negotiations
The government will soon announce the first 10 medications that will be subject to price negotiations with Medicare under a new law. Drugmakers are fighting the measure in court.